POET Technologies' Five-Year, $500M Lumilens Pact Fuels Rally, but $400M Share Sale and Leadership Changes Prompt Retreat

POET shares surged on a $50M Lumilens supply deal, then tumbled 22% after a $400M stock sale, amid CFO retirement, class-action lawsuit, and widening losses.

It was a week of extremes for POET Technologies. The stock rocketed from $7.31 to $20.81 in a single session on the back of a strategic supply agreement with Lumilens, only to shed more than 22% the very next day, closing at $15.97. The 48-hour whipsaw captured the conflicting currents coursing through the company: a transformational revenue opportunity on one side, a massive capital injection and looming legal troubles on the other.

The Lumilens deal, announced on May 14, calls for an initial purchase order of $50 million for POET’s optical engines, built on its optical-interposer platform and aimed at AI networks and hyperscale data centers. The framework has the potential to accumulate more than $500 million in cumulative purchases over five years. Engineering samples are expected by the end of 2026, with volume production slated to begin in 2027.

Hours before the sell-off began, POET disclosed a direct placement of approximately 19 million new shares, accompanied by warrants, to a single institutional investor. The price per unit was set at $21.00 — a premium to the prior day’s Nasdaq close of $20.57. Each unit includes a warrant exercisable at $26.15. The gross proceeds of $400 million will be deployed to expand manufacturing capacity, fund research and development, pursue acquisitions, and accelerate the company’s light-source business.

The cash infusion arrives as POET’s first-quarter results reveal a business scaling quickly but still deep in the red. Revenue tripled to roughly $503,000 from $167,000 a year earlier, fueled by engineering contracts and product sales tied to the optical-interposer platform. Yet selling, general and administrative expenses surged to $12.5 million and R&D spending hit $5.8 million, producing an operating loss of $17.9 million and a net loss of $12.3 million, or $0.08 per share. In the year-ago quarter, the company had reported net income of $6.3 million. Shareholders’ equity, supported by the recent fundraising and warrant-related gains, climbed to $448.6 million.

Amid the financial tumult, POET is reshaping its leadership. Chief Financial Officer Thomas Mika, a ten-year veteran of the company, informed the board of his intention to retire this year. The search for a successor is underway. Mika’s exit comes at a sensitive moment: he and Chief Executive Suresh Venkatesan are named in a securities class-action lawsuit alleging that POET misrepresented its status as a Passive Foreign Investment Company (PFIC), thereby hiding potential tax consequences from U.S. investors. The deadline to name a lead plaintiff is June 29, 2026. Separately, reports have surfaced of an alleged confidentiality breach related to cancelled orders from Celestial AI, and a short seller published a bearish report questioning the company’s partnerships and marketing claims.

On the operational side, POET appointed Sandeep Kumar as its new Chief Operating Officer on May 11. Kumar brings more than 18 years of experience from Silicon Labs, where he served as Senior Vice President of global operations. His immediate mandate is to ramp up the company’s manufacturing facility in Malaysia for mass production of optical engines.

To permanently address the PFIC concern and broaden its appeal to U.S. institutional investors, POET plans to relocate its headquarters to the United States. Whether that move, combined with the Lumilens framework and a new COO, can restore investor confidence will depend heavily on how quickly the Malaysia production line proves its commercial mettle — and how convincingly the company responds to the legal and reputational challenges now converging on its doorstep.